Why Does Immunotherapy Not Benefit Everyone Long-term?
Immunotherapy is revolutionizing the treatment of cancer. As discussed in an earlier post on this blog, immunotherapeutics that work...
Immunotherapy is revolutionizing the treatment of cancer. As discussed in an earlier post on this blog, immunotherapeutics that work...
Much has been written, including on this blog, about the rapidly expanding use of immunotherapy to treat an increasing...
The human microbiome – the collection of bacteria, viruses, fungi, and other microorganisms that live inside and on the...
As the temperature soared this summer, the laps around the park became harder to endure. When her skin chafed...
Every September 24, World Cancer Research Day provides an opportunity to raise awareness about the important role research plays...
The San Antonio Breast Cancer Symposium (SABCS), which marks its 40th anniversary this year, has become the world's premier...
Yesterday marked a much anticipated milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced the...
In recent decades, the cancer research community has made great strides by bringing new, targeted, safer, and longer-lasting treatments...
Today, the American Association for Cancer Research (AACR) released its sixth annual Cancer Progress Report. The report highlights how...
Today, the American Association for Cancer Research (AACR) released its seventh annual Cancer Progress Report. The report highlights how...
After three decades of failed efforts to target the elusive KRAS and its family members NRAS and HRAS, proto-oncogenes...
Women have played many pivotal roles at the American Association for Cancer Research (AACR), from the organization’s earliest years...
The U.S. Latino population surged 243 percent from 1980 to 2010. But in the same time span, the Latino...
Earlier this week, the U.S. Food and Drug Administration (FDA) announced that it had approved a new immune checkpoint...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
A recent estimate suggests that more than 40 percent of cancers could be prevented. Modifiable factors linked to cancer...
On Sunday, almost 300 of the greatest minds in ovarian cancer research will come together in Pittsburgh to discuss...
Cancer Today Senior Editor Marci A. Landsmann shares her experience reporting on a young lung cancer survivor, Emily Bennett...
From Oct. 9-12, the American Association for Cancer Research will host its first major conference in China: New Horizons...
The Opening Ceremony of AACR Annual Meeting 2021 set the stage for a dynamic forum for presenting and sharing...
Week 1 of the AACR Annual Meeting 2021 wrapped up on Thursday. The meeting drew more than 13,500 attendees...
Guest post by Patrick Williams, PhDAACR Scientific Research Analyst In a virtual Congressional briefing on February 9, 2022, the...
Cancer Today empowers readers to be active and involved in their treatment and survivor experiences.
It looks like a toppled ice cream sundae, with maraschino cherries rolling away from a melting scoop of vanilla....
The signature pink ribbons of Breast Cancer Awareness Month have become almost as much a part of October as...
Editor’s note: When the San Antonio Breast Cancer Symposium (SABCS) kicks off next week, researchers will present the results...
Breast cancer is the most common cancer among women in the United States and worldwide, with an estimated 2.1 million women diagnosed each year....
The American Association for Cancer Research (AACR) publishes eight esteemed scientific journals. Each month, these journals feature a wide...
How the latest clinical therapies are helping patients and laboratory research informing future treatments.
Data presented at the San Antonio Breast Cancer Symposium showed that five additional years of the aromatase inhibitor (AI)...